Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,205,933
+$225,537 QoQ
Shares Held
32,731
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1,119
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. MRK ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
|
10,410 | $1,631,455 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,205,933 | 32,731 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,980,396 | 33,090 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,398,003 | 32,282 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,761,632 | 32,904 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,792,052 | 35,271 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,040,725 | 45,017 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,499,480 | 45,230 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,335,503 | 46,984 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,813,648 | 46,960 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,221,574 | 47,151 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,148,360 | 47,224 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,726,995 | 36,202 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,209,888 | 36,484 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,735,991 | 35,116 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,831,103 | 34,530 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,014,113 | 34,999 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,226,323 | 35,388 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,958,394 | 36,056 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,725,701 | 35,565 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,613,302 | 34,793 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,704,685 | 34,778 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,596,469 | 33,681 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,771,382 | 33,880 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,875,877 | 34,670 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,331,809 | 30,154 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,164,859 | 28,137 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||